Impact of Immunohistochemical <scp>PSA</scp> and Ki‐67 Expression on Prognosis in Metastatic Castration‐Sensitive Prostate Cancer
Immunohistochemical PSA and Ki-67 expression provide practical prognostic information for patients with metastatic castration-sensitive prostate cancer. Combined assessment with EOD ≥ 3 identifies a high-risk subgroup with unfavorable clinical outcomes.
Authors
- Miyaka Umemori
- Yuya Iwamoto (ORCID: https://orcid.org/0009-0009-1396-3192)
- Shun Sato (ORCID: https://orcid.org/0000-0002-1650-6239)
- Kojiro Tashiro
- Yu Imai
- Takahiro Kimura
- Hiroyuki Takahashi
- Fumihiko Urabe
Institutions
- Jikei University School of Medicine (JP)
- Juntendo University (JP)
- Kanagawa Rehabilitation Hospital (JP)
- Tsurugi Hospital (JP)
Publication Details
- Journal
- International Journal of Urology
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1111/iju.70368
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00